MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Parkinson’s Disease, Cognition, Positive Symptoms and Medication Management

    O. Kaczmarek, S. Baek, A. Sethi, A. Stolarczyk, B. Bumstead, M. Buhse, M. Zarif, B. Anand, M. Gudesblatt (Patchogue, USA)

    Objective: Explore the relationship between multi-domain cognitive testing and patient-reported psychiatric symptoms in PwPD to self-medication management capabilities. Background: Parkinson’s disease (PD) is a complex…
  • 2022 International Congress

    Cerebro-cerebellar motor networks in clinical subtypes of Parkinson’s disease

    F. Agosta, S. Basaia, A. Francia, C. Cividini, R. Balestrino, T. Stojkovic, I. Stankovic, V. Markovic, E. Sarasso, A. Gardoni, R. de Micco, L. Albano, E. Stefanova, VS. Kostic, M. Filippi (Milan, Italy)

    Objective: This study investigated functional alterations within the cerebro-cerebellar system in tremor-dominant (TD) and postural-instability-and-gait-disorder (PIGD) subtypes of Parkinson’s disease (PD) using stepwise functional connectivity…
  • 2022 International Congress

    Reduced Risk of Mortality and Antipsychotics in Parkinson’s Disease-Related Psychosis: Pimavanserin vs Off-Label Antipsychotics

    S. Isaacson, F. Pagan, D. Truong, V. Abler, R. Pahwa (Boca Raton, USA)

    Objective: Summarize the available data for the mortality risk associated with Parkinson’s disease (PD) psychosis (PDP) and pimavanserin. Background: PDP is associated with increased mortality…
  • 2022 International Congress

    Developmental Validity of the revised improved version of the Fragile X-associated Tremor Ataxia Syndrome Rating Scale (FXTAS-RS)

    M. Tosin, G. Stebbins, C. Goetz, R. Hagerman, D. Hessl, M. Zolecki, P. Todd, M. Leehey, D. Hall (Chicago, USA)

    Objective: To qualitatively validate the revised improved version of the Fragile X-associated Tremor Ataxia Syndrome Rating Scale (FXTAS-RS) for motor signs assessment. Background: Clinimetric analyses…
  • 2022 International Congress

    Amelioration of Levodopa-induced Dyskinesias using Genetic Silencing of Striatal CaV1.3 in Parkinsonian Rats: Impact of Sex and Advancing Age

    M. Caulfield, F. Manfredsson, J. Stancati, C. Sortwell, S. Boezwinkle, M. Vanderwerp, T. Collier, K. Collier (Grand Rapids, USA)

    Objective: To advance understanding of striatal CaV1.3 (cacna1d) channel silencing as a therapeutic approach to reduce levodopa-induced dyskinesias (LID), a side effect of long-term escalating…
  • 2022 International Congress

    Symptomatic brain calcifications in two patients with JAM2 monoallelic variants.

    S. Andretta, G. Bonato, M. Mainardi, L. Salviati, A. Antonini, M. Carecchio (Padova, Italy)

    Objective: To describe two subjects carrying monoallelic JAM2 genetic variant associated with brain calcification. Background: Primary Familial Brain Calcification (PFBC) is a rare neurodegenerative disorder…
  • 2022 International Congress

    ASYMMETRIC EARLY-ONSET PARKINSONISM DUE TO PSEN1 MUTATION

    E. Luque-Buzo, J. Pérez Sáchez, M. Gonzalez-Sanchez, A. Contreras-Chicote, S. Secades, B. Casa-Fages, F. Grandas (Madrid, Spain)

    Objective: To report a novel case of early-onset parkinsonism due to a presenilin 1 gene (PSEN1) mutation. Background: Mutations in PSEN1 gene are the most…
  • 2022 International Congress

    “Happy fix” transiently improves cervical dystonia

    E. Shamim, S. Grant, C. Amini (Largo, USA)

    Objective: To describe an emotional trick that has not been described in patient with cervical dystonia. Background: Geste antagoniste is a sensory trick that can…
  • 2022 International Congress

    A randomized, sham-controlled, crossover trial on Transcranial pulsed current stimulation (tPCS) in Huntington disease

    M. Tuesta Bernaola, Y. Tamilselvam, Y. Mahdi, J. Ganguly, D. Aur, M. Jog (London, Canada)

    Objective: 1. To assess brain network level dysfunction of Huntington disease (HD). 2.  To evaluate the effectiveness of 2-week home-based chronic non-invasive transcranial brain stimulation (NIBS) in…
  • 2022 International Congress

    Has the COVID-19 pandemic had an impact on Functional Movement Disorders phenotype?: experience from a specialized Unit in Spain.

    A. López-Jiménez, JD. Guerra-Hiraldo, M. Kurtis, I. Pareés (Madrid, Spain)

    Objective: To assess the prevalence of paroxysmal functional movement disorders (PFMD) seen in a specialized Unit before and after the COVID-19 pandemic. Background: COVID-19 pandemic…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley